BridgeBio Pharma, Inc. (BBIO)
USD 31.06
(-8.83%)
USD 31.06
(-8.83%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.88 Billion USD | 1.12% |
| 2022 | 1.86 Billion USD | -0.55% |
| 2021 | 1.87 Billion USD | 215.32% |
| 2020 | 595.7 Million USD | 282.59% |
| 2019 | 155.7 Million USD | -72.51% |
| 2018 | 566.44 Million USD | 270.88% |
| 2017 | 152.72 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.88 Billion USD | -0.14% |
| 2024 Q2 | 1.87 Billion USD | -0.52% |
| 2023 Q1 | 1.83 Billion USD | -1.53% |
| 2023 Q4 | 1.88 Billion USD | 2.17% |
| 2023 FY | 1.88 Billion USD | 1.12% |
| 2023 Q3 | 1.84 Billion USD | -0.25% |
| 2023 Q2 | 1.85 Billion USD | 0.76% |
| 2022 Q3 | 1.85 Billion USD | -0.97% |
| 2022 FY | 1.86 Billion USD | -0.55% |
| 2022 Q4 | 1.86 Billion USD | 0.48% |
| 2022 Q2 | 1.87 Billion USD | 1.26% |
| 2022 Q1 | 1.85 Billion USD | -1.31% |
| 2021 Q1 | 1.48 Billion USD | 148.68% |
| 2021 Q2 | 1.53 Billion USD | 3.76% |
| 2021 Q3 | 1.51 Billion USD | -1.28% |
| 2021 Q4 | 1.87 Billion USD | 23.79% |
| 2021 FY | 1.87 Billion USD | 215.32% |
| 2020 Q3 | 569.3 Million USD | -1.46% |
| 2020 Q1 | 537.72 Million USD | 245.35% |
| 2020 FY | 595.7 Million USD | 282.59% |
| 2020 Q4 | 595.7 Million USD | 4.64% |
| 2020 Q2 | 577.71 Million USD | 7.44% |
| 2019 FY | 155.7 Million USD | -72.51% |
| 2019 Q4 | 155.7 Million USD | 33.92% |
| 2019 Q3 | 116.26 Million USD | -80.4% |
| 2019 Q2 | 593.09 Million USD | 553.81% |
| 2019 Q1 | 90.71 Million USD | -83.99% |
| 2018 Q4 | 566.44 Million USD | 0.0% |
| 2018 FY | 566.44 Million USD | 270.88% |
| 2018 Q1 | - USD | 0.0% |
| 2017 FY | 152.72 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -462.552% |
| Alkermes plc | 933.53 Million USD | -102.34% |
| Agenus Inc. | 462.29 Million USD | -308.595% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 53.366% |
| Aptorum Group Limited | 5.25 Million USD | -35833.216% |
| Ardelyx, Inc. | 130.76 Million USD | -1344.533% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -294.848% |
| Bicycle Therapeutics plc | 224.41 Million USD | -741.717% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -1350.668% |
| ChromaDex Corporation | 26.5 Million USD | -7025.83% |
| Chimerix, Inc. | 19.74 Million USD | -9466.548% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -5269.727% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -2502.994% |
| CRISPR Therapeutics AG | 346.76 Million USD | -444.72% |
| Precision BioSciences, Inc. | 140.92 Million USD | -1240.417% |
| Dyadic International, Inc. | 2.34 Million USD | -80600.412% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -11514.8% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1038.319% |
| Lantern Pharma Inc. | 2.73 Million USD | -68846.505% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -2542.578% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -53429.674% |
| Incyte Corporation | 1.59 Billion USD | -18.63% |
| IO Biotech, Inc. | 17.55 Million USD | -10659.37% |
| Jaguar Health, Inc. | 45.86 Million USD | -4018.334% |
| Novavax, Inc. | 2.57 Billion USD | 26.566% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -5138.546% |
| Opthea Limited | 264.6 Million USD | -613.872% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -1345.152% |
| ContextLogic Inc. | 206 Million USD | -816.949% |
| MiMedx Group, Inc. | 96.33 Million USD | -1860.879% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -3833.437% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -53427.217% |
| NextCure, Inc. | 14.99 Million USD | -12495.286% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -46632.187% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -28189.876% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -3941.411% |
| Vaxcyte, Inc. | 167.44 Million USD | -1028.054% |
| PDS Biotechnology Corporation | 33.25 Million USD | -5579.387% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -703.062% |
| Pharming Group N.V. | 244.07 Million USD | -673.914% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -15743.944% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -1378.128% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -28488.395% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -28488.395% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -2191.455% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -28334.668% |
| Acelyrin, Inc. | 86.35 Million USD | -2087.434% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -145286.037% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -13036.623% |
| Summit Therapeutics Inc. | 125.25 Million USD | -1408.031% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -19827.366% |
| Senti Biosciences, Inc. | 52.57 Million USD | -3493.074% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -2646.434% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -1146.71% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -96470.297% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -141332.009% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -732.737% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -20065.635% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -730.493% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -281.978% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -17207.266% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -6766.035% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -15504.808% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -288.186% |
| Immix Biopharma, Inc. | 3.72 Million USD | -50652.959% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -4895.544% |
| MEI Pharma, Inc. | 8.35 Million USD | -22508.199% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -6410.133% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -443.448% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -1194.939% |
| Fortress Biotech, Inc. | 165.93 Million USD | -1038.319% |
| Precigen, Inc. | 41.64 Million USD | -4435.864% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -3683.126% |
| AlloVir, Inc. | 45.01 Million USD | -4096.19% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -1349.255% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -1270.766% |
| ImmuCell Corporation | 18.81 Million USD | -9939.397% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -6592.11% |
| Onconetix, Inc. | 23.18 Million USD | -8048.588% |
| PureTech Health plc | 125.58 Million USD | -1404.117% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -21005.196% |
| Elevation Oncology, Inc. | 34.28 Million USD | -5409.932% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -77156.237% |
| Seer, Inc. | 39.36 Million USD | -4698.463% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -2954.816% |
| Innoviva, Inc. | 568.55 Million USD | -232.233% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -6837.399% |
| ESSA Pharma Inc. | 3.49 Million USD | -53945.111% |
| GlycoMimetics, Inc. | 6.9 Million USD | -27267.354% |
| GT Biopharma, Inc. | 6.63 Million USD | -28377.537% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -614.443% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -593.722% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -2148.013% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -19225.916% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -6852.464% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -58456.972% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -2460.65% |
| Aptose Biosciences Inc. | 15.8 Million USD | -11848.578% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -17010.224% |
| Soligenix, Inc. | 7.27 Million USD | -25864.81% |
| Century Therapeutics, Inc. | 175.94 Million USD | -973.607% |
| Kura Oncology, Inc. | 51.66 Million USD | -3556.295% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -1457.457% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -45603.242% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -28459.97% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -647.795% |
| Autolus Therapeutics plc | 263.9 Million USD | -615.75% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -17920.559% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -2025.696% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -3927.623% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -435.322% |
| GRI Bio, Inc. | 2.69 Million USD | -69937.634% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -233218.923% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -5975.44% |
| IGM Biosciences, Inc. | 220.17 Million USD | -757.908% |
| INmune Bio, Inc. | 18.86 Million USD | -9914.394% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -636.479% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -6990.04% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -69386.125% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -57484.202% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -3131.4% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -1864.366% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -613.512% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -129.508% |
| Verastem, Inc. | 71.18 Million USD | -2553.53% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -3741.132% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -4796.353% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -3760.286% |
| Histogen Inc. | 5.69 Million USD | -33056.31% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -42970.796% |
| Surrozen, Inc. | 8.14 Million USD | -23091.099% |
| Organovo Holdings, Inc. | 2.74 Million USD | -68637.809% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -601737.455% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -3259.272% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -11339.65% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -3596.29% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -228340.212% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -1390.562% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -17367.973% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -1151.857% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -72345.917% |
| Apollomics, Inc. | 14.15 Million USD | -13246.393% |
| Amarin Corporation plc | 279.58 Million USD | -575.609% |
| Mesoblast Limited | 188.79 Million USD | -900.495% |
| Turnstone Biologics Corp. | 14.14 Million USD | -13251.11% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -944.823% |
| Synaptogenix, Inc. | 5.52 Million USD | -34060.875% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -28313.282% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -1010.421% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -21974.003% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -107383.926% |
| Exelixis, Inc. | 678.44 Million USD | -178.418% |
| Better Therapeutics, Inc. | 23.84 Million USD | -7822.637% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -1051.454% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -217.887% |
| NLS Pharmaceutics AG | 10.68 Million USD | -17586.132% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -116240.009% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -4752.455% |
| Gritstone bio, Inc. | 125.91 Million USD | -1400.103% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -12770.775% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -37020.327% |
| Avid Bioservices, Inc. | 275.66 Million USD | -585.214% |
| Insmed Incorporated | 1.66 Billion USD | -13.67% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -24450.417% |
| MediWound Ltd. | 27.18 Million USD | -6847.861% |
| OmniAb, Inc. | 87.4 Million USD | -2061.23% |
| Alector, Inc. | 487.66 Million USD | -287.335% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -368.184% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -10151.913% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -4822.511% |
| Zai Lab Limited | 240.17 Million USD | -686.468% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -199.8% |
| Aura Biosciences, Inc. | 29.22 Million USD | -6362.911% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -1886.721% |
| Immunic, Inc. | 25.36 Million USD | -7346.054% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -2628.227% |
| Veracyte, Inc. | 93.71 Million USD | -1915.509% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -72087.66% |
| FibroGen, Inc. | 585.72 Million USD | -222.49% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -10766.45% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -289133.565% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -33299.859% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 75.329% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -22941.169% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -2148.12% |
| TG Therapeutics, Inc. | 169.08 Million USD | -1017.139% |
| Galecto, Inc. | 5.89 Million USD | -31937.229% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -22701.968% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 27.86% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -6453.726% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -14866.445% |
| XBiotech Inc. | 8.39 Million USD | -22395.117% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -12770.775% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -3451.927% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -420.21% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -6926.168% |
| Theravance Biopharma, Inc. | 169 Million USD | -1017.675% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -55.39% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -277.461% |
| Vaxxinity, Inc. | 30.94 Million USD | -6004.301% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -94.235% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -31219.541% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -153.466% |
| NexImmune, Inc. | 5.08 Million USD | -37052.416% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -508501.378% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -61331.167% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 73.422% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -36549.282% |
| Scopus BioPharma Inc. | 7.45 Million USD | -25239.483% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -7083.825% |
| Ainos, Inc. | 7.39 Million USD | -25445.821% |
| Pluri Inc. | 34.11 Million USD | -5437.392% |
| Prothena Corporation plc | 135.01 Million USD | -1299.02% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -677.002% |
| Celularity Inc. | 102.92 Million USD | -1735.163% |
| Rallybio Corporation | 9.43 Million USD | -19918.175% |
| Cue Biopharma, Inc. | 24.44 Million USD | -7627.204% |
| MeiraGTx Holdings plc | 319.99 Million USD | -490.303% |
| Omeros Corporation | 403.25 Million USD | -368.42% |
| Humacyte, Inc. | 114.67 Million USD | -1547.161% |
| Immunocore Holdings plc | 228.15 Million USD | -727.898% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -38646.974% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -2361.448% |
| Blueprint Medicines Corporation | 918.64 Million USD | -105.621% |
| CalciMedica, Inc. | 4.02 Million USD | -46794.613% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -10723.487% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -1125.43% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -2101.097% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -579.972% |
| Pulmatrix, Inc. | 15.96 Million USD | -11733.083% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -11875.623% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -7576.644% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -653.132% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -3619.361% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -56.026% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -5843.161% |
| Nutriband Inc. | 1.07 Million USD | -174974.774% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -17664.648% |
| Vor Biopharma Inc. | 59.1 Million USD | -3095.917% |
| Roivant Sciences Ltd. | 773.95 Million USD | -144.061% |
| Evogene Ltd. | 17.99 Million USD | -10399.805% |
| ProKidney Corp. | 29.21 Million USD | -6365.344% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -2524.258% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -267837.667% |
| CorMedix Inc. | 11.91 Million USD | -15749.889% |
| BioLineRx Ltd. | 50.7 Million USD | -3625.524% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -1163.835% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -2035.791% |
| Atai Life Sciences N.V. | 49.16 Million USD | -3742.226% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -5963.484% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -10416.173% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -1415.545% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -33308.472% |
| MediciNova, Inc. | 3.89 Million USD | -48438.848% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -10233.798% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -125472.631% |
| GeoVax Labs, Inc. | 3.51 Million USD | -53564.172% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -375.487% |
| Biomea Fusion, Inc. | 30.69 Million USD | -6054.822% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 30.599% |
| Mereo BioPharma Group plc | 15.96 Million USD | -11733.824% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -5954.021% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -3118.79% |
| Absci Corporation | 58.3 Million USD | -3139.769% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -9816.605% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -5791.445% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -2459.852% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -2059.179% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -5493.471% |
| Allakos Inc. | 74.79 Million USD | -2425.524% |
| Imunon, Inc. | 8.53 Million USD | -22043.264% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -8294.805% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -1545.224% |
| BioAtla, Inc. | 48.98 Million USD | -3756.03% |
| NLS Pharmaceutics AG | 10.68 Million USD | -17586.132% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -67871.033% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -1346.292% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -13188.181% |
| XOMA Corporation | 145.58 Million USD | -1197.51% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -5510.916% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -2647.153% |
| aTyr Pharma, Inc. | 31.59 Million USD | -5878.147% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -2955.36% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -4100.856% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -3802.556% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -65715.854% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -23054.092% |
| Akari Therapeutics, Plc | 4.58 Million USD | -41106.697% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -10551.898% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -14.517% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -467559.715% |
| UroGen Pharma Ltd. | 243.52 Million USD | -675.662% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -488.288% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -68300.338% |
| Orgenesis Inc. | 35.53 Million USD | -5215.647% |
| Entera Bio Ltd. | 1.37 Million USD | -136877.157% |
| GH Research PLC | 6.7 Million USD | -28088.554% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -27678.162% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -9933.544% |
| Xencor, Inc. | 283.55 Million USD | -566.145% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -63165.928% |
| Replimune Group, Inc. | 113.21 Million USD | -1568.446% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -50175.543% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -1724.51% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -467559.715% |
| Portage Biotech Inc. | 4.45 Million USD | -42347.528% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -125472.631% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -8094.859% |
| OncoCyte Corporation | 49.29 Million USD | -3731.626% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -45561.205% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -236759.297% |
| Purple Biotech Ltd. | 10 Million USD | -18779.71% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -32546.301% |
| scPharmaceuticals Inc. | 57.26 Million USD | -3198.781% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -15147.916% |
| HilleVax, Inc. | 78.9 Million USD | -2293.789% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -37304.257% |
| Tharimmune, Inc. | 1.81 Million USD | -103969.814% |
| Genprex, Inc. | 3.25 Million USD | -57945.306% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -6865.283% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -35975.535% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -916849.029% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -526723.466% |
| OKYO Pharma Limited | 7.42 Million USD | -25354.173% |
| Savara Inc. | 37.19 Million USD | -4978.821% |
| Curis, Inc. | 57.61 Million USD | -3178.683% |
| Daré Bioscience, Inc. | 26.32 Million USD | -7074.043% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -4718.686% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -130711.288% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -8973.034% |
| BeiGene, Ltd. | 2.23 Billion USD | 15.437% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -8772.394% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -619.869% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -8778.984% |
| Erasca, Inc. | 78.61 Million USD | -2302.863% |
| bluebird bio, Inc. | 424.62 Million USD | -344.844% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -288173.061% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 0.06% |
| DBV Technologies S.A. | 42.8 Million USD | -4313.353% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -288173.061% |
| Moderna, Inc. | 4.57 Billion USD | 58.685% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -26903.788% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -113964.915% |
| Molecular Templates, Inc. | 31.17 Million USD | -5959.847% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -10965.7% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -221.188% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -1417.14% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -6784.554% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -5081.356% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -3295.192% |
| MacroGenics, Inc. | 154.2 Million USD | -1124.922% |
| RenovoRx, Inc. | 4.46 Million USD | -42195.455% |
| Adicet Bio, Inc. | 37.12 Million USD | -4988.672% |
| Prime Medicine, Inc. | 60.78 Million USD | -3007.79% |
| Aditxt, Inc. | 28.53 Million USD | -6520.441% |
| Adagene Inc. | 45.16 Million USD | -4081.852% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1045226.257% |
| Quantum-Si incorporated | 26.63 Million USD | -6992.918% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -170.787% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -61985.571% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -1543.092% |
| SciSparc Ltd. | 1.59 Million USD | -118327.273% |
| Vericel Corporation | 127.7 Million USD | -1379.124% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -33843.414% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -2112.93% |
| Generation Bio Co. | 171.63 Million USD | -1000.574% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -16254.242% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -4415.587% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -647.499% |
| Invivyd, Inc. | 51.71 Million USD | -3552.689% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -1953.682% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -28936.774% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -2402.007% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -184906.366% |
| 2seventy bio, Inc. | 310.12 Million USD | -509.08% |
| ADMA Biologics, Inc. | 193.97 Million USD | -873.788% |
| Clene Inc. | 38.95 Million USD | -4749.465% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -5127.693% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -635.055% |
| GeoVax Labs, Inc. | 3.51 Million USD | -53564.172% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -892.792% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -15408.764% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -852.449% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -15389.512% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -3826.16% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -3474.715% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -410.719% |
| Evaxion Biotech A/S | 17.61 Million USD | -10621.823% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -1073.757% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -1133.086% |
| Trevena, Inc. | 48.26 Million USD | -3813.876% |
| Surrozen, Inc. | 8.14 Million USD | -23091.099% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -8647.002% |
| Cingulate Inc. | 10.36 Million USD | -18131.248% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -68587.818% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -4965.202% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -52567.07% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -14264.373% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -495.495% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -7501.574% |
| Clearmind Medicine Inc. | 3.61 Million USD | -52224.399% |
| Kronos Bio, Inc. | 54.2 Million USD | -3385.019% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -3915.295% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -8199.373% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -9311.165% |
| Statera Biopharma, Inc. | 22.67 Million USD | -8229.852% |
| ImmunityBio, Inc. | 1.09 Billion USD | -73.233% |
| Korro Bio, Inc. | 51.75 Million USD | -3549.936% |
| Kineta, Inc. | 7.22 Million USD | -26055.012% |
| BioVie Inc. | 9.7 Million USD | -19369.075% |
| Codexis, Inc. | 49.94 Million USD | -3681.914% |
| Celularity Inc. | 102.92 Million USD | -1735.163% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -1862.57% |
| Celcuity Inc. | 51.45 Million USD | -3571.355% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -547103.891% |
| Cibus, Inc. | 206.11 Million USD | -816.429% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -4347.122% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -7071.552% |
| IN8bio, Inc. | 8.77 Million USD | -21433.459% |
| Kodiak Sciences Inc. | 213.59 Million USD | -784.361% |
| Annexon, Inc. | 47.11 Million USD | -3908.903% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -2009.553% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -1860.025% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -13698.78% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 27.444% |
| Eyenovia, Inc. | 19.78 Million USD | -9449.486% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -966.665% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -24492.045% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -7738.147% |
| Arcellx, Inc. | 339.75 Million USD | -455.969% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -15775.904% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -669.29% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -19652.327% |
| Moolec Science SA | 13.94 Million USD | -13445.119% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -4277.352% |
| Geron Corporation | 146.12 Million USD | -1192.653% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -3638.057% |
| Royalty Pharma plc | 6.29 Billion USD | 70.006% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -4648.881% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -641502.073% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -76676.361% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -898.602% |
| Humacyte, Inc. | 114.67 Million USD | -1547.161% |
| Structure Therapeutics Inc. | 29.05 Million USD | -6402.064% |
| 89bio, Inc. | 59.96 Million USD | -3050.134% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -7037.947% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -157836.037% |
| Genelux Corporation | 8.42 Million USD | -22333.67% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -27451.269% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -1285.658% |
| Notable Labs, Ltd. | 4.42 Million USD | -42568.06% |
| Liquidia Corporation | 73.13 Million USD | -2482.672% |
| Mustang Bio, Inc. | 17.61 Million USD | -10620.898% |
| Immunovant, Inc. | 48.95 Million USD | -3758.472% |
| Quantum-Si incorporated | 26.63 Million USD | -6992.918% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -4821.228% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -60773.832% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -2457.392% |
| Acasti Pharma Inc. | 11.55 Million USD | -16244.337% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -8255.173% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -69386.125% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -5022.204% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -138501.173% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -30886.138% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -7505.859% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -8047.494% |
| PepGen Inc. | 34.63 Million USD | -5354.405% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -15454.307% |
| United Therapeutics Corporation | 1.18 Billion USD | -59.78% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -26946.32% |
| Solid Biosciences Inc. | 38.45 Million USD | -4811.631% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -21974.003% |
| Immuneering Corporation | 12 Million USD | -15630.006% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -601737.455% |
| Silo Pharma, Inc. | 1.56 Million USD | -120269.025% |
| Belite Bio, Inc | 4.21 Million USD | -44756.685% |
| XOMA Corporation | 145.58 Million USD | -1197.51% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -77697.158% |
| Bionomics Limited | 10.15 Million USD | -18494.024% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -8689.33% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -8143.857% |
| uniQure N.V. | 624.01 Million USD | -202.702% |
| Cassava Sciences, Inc. | 14.19 Million USD | -13206.904% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -1045226.257% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -1009.925% |
| Forte Biosciences, Inc. | 3.66 Million USD | -51425.232% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -724780.364% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -27896.369% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -24492.045% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -10766.45% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -17773.912% |
| Altimmune, Inc. | 16.54 Million USD | -11319.594% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -205.795% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -8143.857% |
| Compugen Ltd. | 55.77 Million USD | -3286.67% |
| Peak Bio, Inc. | 20.75 Million USD | -9001.729% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -1609.998% |
| Benitec Biopharma Inc. | 4.96 Million USD | -37967.614% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -1096.705% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -2412.724% |
| Zura Bio Limited | 21.29 Million USD | -8771.478% |
| PolyPid Ltd. | 17.46 Million USD | -10713.573% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -1580.544% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -2412.724% |
| Instil Bio, Inc. | 99.8 Million USD | -1792.681% |
| argenx SE | 444.95 Million USD | -324.522% |
| Immunome, Inc. | 28.65 Million USD | -6491.231% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -22557.011% |
| Verona Pharma plc | 58.84 Million USD | -3110.202% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -12951.302% |
| Shattuck Labs, Inc. | 14.85 Million USD | -12612.262% |
| CervoMed Inc. | 2.59 Million USD | -72669.611% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -38654.924% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -14731.305% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -17829.9% |
| Moolec Science SA | 13.94 Million USD | -13445.119% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -80502.167% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -3297.617% |
| AnaptysBio, Inc. | 364.28 Million USD | -418.525% |
| Design Therapeutics, Inc. | 11.95 Million USD | -15698.888% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -14792.108% |
| NeurAxis, Inc. | 1.91 Million USD | -98654.456% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -4752.33% |
| Lumos Pharma, Inc. | 13.33 Million USD | -14067.217% |
| Achilles Therapeutics plc | 19.08 Million USD | -9796.343% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -12951.302% |
| 180 Life Sciences Corp. | 5.38 Million USD | -34962.961% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -7907.952% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -8199.373% |
| Nutriband Inc. | 1.07 Million USD | -174974.774% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -6073.328% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -12917.125% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -370.729% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -5716.879% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -14375.447% |
| Palisade Bio, Inc. | 2.73 Million USD | -68863.673% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -35858.785% |
| Beam Therapeutics Inc. | 478.38 Million USD | -294.852% |
| Neurogene Inc. | 36.54 Million USD | -5068.171% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -374.66% |
| AEON Biopharma, Inc. | 159.88 Million USD | -1081.391% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -3864.145% |
| Sesen Bio, Inc. | 30.98 Million USD | -5996.421% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -7175.972% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -24746.9% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -865.022% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -883.518% |
| Athira Pharma, Inc. | 30.05 Million USD | -6184.443% |
| Vaccinex, Inc. | 5.94 Million USD | -31689.212% |
| HCW Biologics Inc. | 15.05 Million USD | -12449.31% |
| XOMA Corporation | 145.58 Million USD | -1197.51% |
| Nektar Therapeutics | 267.04 Million USD | -607.337% |
| Arvinas, Inc. | 644.6 Million USD | -193.037% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -10551.898% |
| Merus N.V. | 102.15 Million USD | -1749.14% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -1190.683% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -1885.823% |
| Rezolute, Inc. | 11.73 Million USD | -15997.793% |
| Clene Inc. | 38.95 Million USD | -4749.465% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -66238.704% |
| BeyondSpring Inc. | 48.26 Million USD | -3813.309% |
| Synlogic, Inc. | 32.89 Million USD | -5642.256% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -12826.264% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -115500.673% |
| Peak Bio, Inc. | 20.75 Million USD | -9001.729% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -2876.591% |
| Krystal Biotech, Inc. | 39.71 Million USD | -4656.295% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -401.512% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -1797.091% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -436415.254% |
| MannKind Corporation | 721.36 Million USD | -161.853% |
| Ikena Oncology, Inc. | 22.33 Million USD | -8357.197% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -90452.013% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -1741.227% |
| Gossamer Bio, Inc. | 249.14 Million USD | -658.153% |
| CohBar, Inc. | 1.03 Million USD | -182644.346% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -17571.578% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -9816.605% |
| Legend Biotech Corporation | 589.93 Million USD | -220.191% |
| Mural Oncology plc | 37.92 Million USD | -4880.265% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -1324.134% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -82193.76% |
| Disc Medicine, Inc. | 22.87 Million USD | -8157.552% |
| Champions Oncology, Inc. | 28.03 Million USD | -6637.703% |
| REGENXBIO Inc. | 262.22 Million USD | -620.333% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -56128.552% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -14970.329% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -13963.188% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -8807.876% |
| Vaxart, Inc. | 34.02 Million USD | -5451.55% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -9164.263% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -6520.366% |
| Cellectis S.A. | 249.57 Million USD | -656.853% |
| Longeveron Inc. | 5.33 Million USD | -35292.824% |
| Repare Therapeutics Inc. | 41.81 Million USD | -4416.882% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 21.467% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -3029.0% |
| Revolution Medicines, Inc. | 262.39 Million USD | -619.869% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -89549.502% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -21797.925% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -15906.398% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -13350.936% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -87715.667% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 63.321% |
| Denali Therapeutics Inc. | 122.96 Million USD | -1436.165% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -33843.414% |
| Veru Inc. | 32.81 Million USD | -5656.657% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -27399.127% |
| Cingulate Inc. | 10.36 Million USD | -18131.248% |
| Passage Bio, Inc. | 39.26 Million USD | -4711.051% |
| Context Therapeutics Inc. | 4.19 Million USD | -44963.059% |
| Exicure, Inc. | 8.54 Million USD | -21995.157% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -6301.366% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -17913.685% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -8470.006% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -1058.943% |
| Nuvalent, Inc. | 31.82 Million USD | -5835.691% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -29592.326% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -2897.231% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -10393.972% |
| OmniAb, Inc. | 87.4 Million USD | -2061.23% |
| Anew Medical, Inc. | 8.24 Million USD | -22818.722% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -4833.298% |
| Lipocine Inc. | 2.63 Million USD | -71677.405% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -7089.841% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -4597.391% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -6990.04% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -2092.487% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -34873.431% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -2182.759% |
| Ocugen, Inc. | 23.98 Million USD | -7776.058% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -3970.323% |
| Q32 Bio Inc. | 233.12 Million USD | -710.248% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -20735.153% |
| Alumis Inc. Common Stock | 53.5 Million USD | -3430.55% |
| Equillium, Inc. | 27.95 Million USD | -6656.501% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -814.321% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -33470.774% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -30699.362% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -1100.638% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -2620.486% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -18838.008% |
| Dominari Holdings Inc. | 4.63 Million USD | -40653.29% |
| Edesa Biotech, Inc. | 1.84 Million USD | -102467.173% |
| vTv Therapeutics Inc. | 29.56 Million USD | -6288.592% |
| Bio-Techne Corporation | 744.34 Million USD | -153.77% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -1397.962% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -448.376% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -4555.367% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -6423.172% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -1945.166% |
| Nkarta, Inc. | 105.6 Million USD | -1688.745% |
| BioCardia, Inc. | 4.59 Million USD | -41052.832% |
| Iterum Therapeutics plc | 32.66 Million USD | -5683.219% |